Reaction to Trump’s selection of RFK Jr. for HHS leadership
Leaders in the biopharma world and scientific community were taken aback by the news that President-elect Donald Trump has chosen Robert F. Kennedy Jr. to lead the Department of Health and Human Services. This...
Understanding Generalized Pustular Psoriasis in Adults: Symptoms, Treatments, and Images
Generalized Pustular Psoriasis (GPP) is a skin condition that can affect individuals of any age, but it is most commonly seen in middle-aged adults, with a higher prevalence in women. The condition is characterized...
Global Measles Cases Increase by 20% in 2023: New Report
Measles vaccination coverage has not yet returned to pre-Covid levels globally, leading to a 20% increase in measles cases in 2023 compared to the previous year, as per a recent report from the World...
Understanding Guttate Psoriasis in Adults: Causes, Symptoms, Treatment
Guttate psoriasis is a skin condition that can affect people of all ages, races, and genders, but it is most commonly seen in children and individuals under 30 years old. It affects both men...
Merck Expands Portfolio with Licensing of Chinese Cancer Drug
Merck, a leading pharmaceutical company, has recently taken a strategic step to enhance its cancer drug portfolio by acquiring the licensing rights for a new cancer drug from LaNova Medicines, a Chinese firm based...
Understanding Cachexia in Cancer Patients: Causes, Symptoms, and Treatment Options
Cancer cachexia is a condition that causes weakness, fatigue, and loss of muscle and fat in cancer patients. Unlike malnutrition, it cannot be reversed with nutrition support alone. It is most common in people...
Pharmalittle: GSK Leaves BIO, AbbVie Schizophrenia Drug Fails & More – Pharma News Update
Good morning, everyone, and welcome to a new week of work. We hope you had a restful weekend and are ready to dive back into the routine of online meetings and deadlines. Let's start...
Ending 23andMe’s Drug Discovery Dream: What Went Wrong?
23andMe, the genetics company that many people have been excited about, recently made a big announcement. The company has decided to stop working on creating new medicines and will be letting go of 40%...
Implications of a Second Trump Term on Hospitals, Insurers, and Medicare
The healthcare industry has always been a money-making machine, regardless of who is leading the country. It continues to consume the hard-earned savings, wages, and tax dollars of patients and healthcare workers. The cost...
Understanding and Addressing Cardiovascular Health Disparities: Insights from Recent Studies
The recent election results may have shifted focus away from diversity, equity, and inclusion, but new research papers emphasize the importance of addressing health disparities based on socioeconomic factors. These papers, set to be...
Navigating Sickle Cell Pain, Loss, and Survival in America
Today, I want to talk about Tammy Clemons, a woman who is navigating the challenges of living with sickle cell disease in America. Tammy's story is one of pain, loss, and survival, and it...
FDA Plans to Ban Cold Medicine, Eisai’s Alzheimer’s Drug Sales, and More: Pharmalittle Update
As we approach the end of another workweek, it's time to start thinking about weekend plans. Our schedule includes tending to the Pharmalot grounds, spending time with our beloved mascots, and catching up on...
BREAKING NEWS
NIH Funding Approved for Women’s Health Initiative
Elizabeth Cooney, who's a cardiovascular disease reporter at STAT, is covering heart, stroke, and metabolic conditions. On Monday, the Women’s Health Initiative said the...
